Universiti Teknologi MARA, Selangor, Malaysia.
Hospital Ampang, Ministry of Health, Selangor, Malaysia.
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231191017. doi: 10.1177/21501319231191017.
Cardiovascular diseases (CVD) remain the world's leading cause of death. About half of Malaysian adults have at least 2 risk factors; thus, rigorous primary preventions are crucial to prevent the first cardiovascular (CV) event. This study aimed to determine the achievement of treatment targets and factors associated with it among high CV risk individuals.
This cross-sectional study included 390 participants from a primary care clinic in Selangor, Malaysia, between February and June 2022. The inclusion criteria were high-CV risk individuals, that is, Framingham risk score >20%, diabetes without target organ damage, stage 3 kidney disease, and very high levels of low-density lipoprotein cholesterol (LDL-C) >4.9 mmol/L or blood pressure (BP) >180/110 mmHg. Individuals with existing CVD were excluded. The treatment targets were BP <140/90 mmHg (≤135/75 for diabetics), LDL-C <2.6 mmol/L, and HbA1c ≤6.5%. Multiple logistic regressions determined the association between sociodemographic, clinical characteristics, health literacy, and medication adherence with the achievements of each target.
About 7.2% achieved all treatment targets. Of these, 35.1% reached systolic and diastolic (46.7%) BP targets. About 60.2% and 28.2% achieved optimal LDL-C and HbA1c, respectively. Working participants had lower odds of having optimal systolic (aOR = 0.34, 95% CI: 0.13-0.90) and diastolic (aOR = 0.41, 95% CI: 0.17-0.96) BP. Those who adhered to treatments were more likely to achieve LDL-C and HbA1c targets; (aOR = 1.72, 95% CI: 1.10-2.69) and (aOR = 2.46, 95% CI: 1.25-4.83), respectively.
The control of risk factors among high CV risk patients in this study was suboptimal. Urgent measures such as improving medication adherence are warranted.
心血管疾病(CVD)仍然是全球死亡的主要原因。大约一半的马来西亚成年人至少有 2 个风险因素;因此,严格的一级预防对于预防首次心血管(CV)事件至关重要。本研究旨在确定高 CV 风险个体中治疗目标的实现情况及其相关因素。
本横断面研究纳入了 2022 年 2 月至 6 月期间来自马来西亚雪兰莪州一家初级保健诊所的 390 名参与者。纳入标准为高 CV 风险个体,即弗雷明汉风险评分>20%、无靶器官损伤的糖尿病、3 期肾病和极低水平的低密度脂蛋白胆固醇(LDL-C)>4.9mmol/L 或血压(BP)>180/110mmHg。排除已有 CVD 的个体。治疗目标为 BP<140/90mmHg(糖尿病患者为≤135/75mmHg)、LDL-C<2.6mmol/L 和 HbA1c≤6.5%。多因素逻辑回归确定了社会人口统计学、临床特征、健康素养和药物依从性与每个目标实现之间的关联。
约 7.2%的人实现了所有治疗目标。其中,35.1%达到了收缩压和舒张压(46.7%)的 BP 目标。约 60.2%和 28.2%分别实现了最佳 LDL-C 和 HbA1c。工作参与者达到最佳收缩压(aOR=0.34,95%CI:0.13-0.90)和舒张压(aOR=0.41,95%CI:0.17-0.96)的可能性较低。那些坚持治疗的人更有可能实现 LDL-C 和 HbA1c 目标;(aOR=1.72,95%CI:1.10-2.69)和(aOR=2.46,95%CI:1.25-4.83)。
本研究中高 CV 风险患者的危险因素控制不理想。迫切需要采取措施提高药物依从性。